Intraocular metabolic pathway

The intraocular metabolic pathway refers to the collective biochemical processes, such as glycolysis, the pentose phosphate pathway, and the visual cycle, that maintain the physiological function and structural integrity of the eye (Source: PubMed, PMID: 28603520). These pathways are essential for meeting the high energy demands of the retina and ensuring the transparency of the lens and cornea (Source: NIH, National Eye Institute). Dysregulation of these metabolic systems is a primary driver of ocular diseases, including diabetic retinopathy, where the overactivation of the polyol pathway leads to oxidative stress and microvascular damage (Source: StatPearls, 'Diabetic Retinopathy'). Age-related macular degeneration is also linked to metabolic failure, specifically mitochondrial dysfunction and impaired retinoid recycling in the retinal pigment epithelium (Source: PubMed, PMID: 25134434). While the term describes a broad physiological system rather than a single molecular entity, therapeutic strategies often target specific enzymes or signaling proteins within these pathways, such as aldose reductase or vascular endothelial growth factor (Source: PubChem). Consequently, the 'intraocular metabolic pathway' is considered a conceptual category of biological processes rather than a discrete, druggable target molecule (Source: UniProt). Understanding the interplay between these metabolic routes is crucial for developing multi-target therapies that can address the complex nature of vision loss (Source: PubMed, PMID: 30124340).

Other names

Ocular metabolismRetinal metabolic pathwaysVisual cycleRetinoid cycleOcular glucose metabolism

Modulation of specific enzymatic activities or signaling cascades within the ocular metabolic network to restore physiological homeostasis and prevent tissue damage (Source: PubMed, PMID: 30124340).